✦ LIBER ✦

Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder : A contemporary series

✍ Scribed by Christopher J. Weight; Jorge A. Garcia; Donna E. Hansel; Amr F. Fergany; Steven C. Campbell; Michael C. Gong; J. Stephen Jones; Eric A. Klein; Robert Dreicer; Andrew J. Stephenson

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 159 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A role for neoadjuvant gemcitabine plus

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder : A retrospective experience

✍ Atreya Dash; Joseph A. Pettus IV; Harry W. Herr; Bernard H. Bochner; Guido Dalba 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Tumor size predicts the survival of pati

Tumor size predicts the survival of patients with pathologic stage t2 bladder carcinoma : A critical evaluation of the depth of muscle invasion

✍ Liang Cheng; Roxann M. Neumann; Beth G. Scherer; Amy L. Weaver; Bradley C. Leibo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

## BACKGROUND. Accurate examination of radical cystectomy specimens is critical for stratifying patients into prognostically important groups and determining the need for adjuvant treatment. Evidence has accumulated that cancers invading the superficial muscle wall (T2a) behave similarly to those